Coming soon. Build, review and maintain your IVDR technical documentation and performance evaluation in one AI workspace. Join the early access list.
Your IVDR technical documentation needs to demonstrate that your in vitro diagnostic device is safe and performs as intended. Evidence is often scattered across Word files, spreadsheets and SharePoint folders. Coming soon, Obodux IVDR will bring technical documentation and performance evaluation into one AI workspace for your team to build, review and maintain.
It is being developed for teams preparing a first IVDR submission, transitioning legacy IVDD devices to IVDR, or maintaining documentation throughout the device lifecycle. Join the early access list to hear when it is available.
Every part of your IVDR documentation, in one place
Obodux IVDR is being built around Annex II technical documentation, Annex III post-market surveillance and Annex XIII performance evaluation, so your evidence can be organised against the relevant requirements.
Device description and specification
Intended purpose, analytes, specimen types, variants and UDI information, with a Class A, B, C or D classification rationale under IVDR Annex VIII.
Labelling and IFU
Labels, instructions for use and translations, consistent with the IVD’s intended purpose, users and performance claims.
Design and manufacturing
Design stages, manufacturing sites, suppliers and key processes documented under Annex II.
GSPR checklist
Applicable IVDR Annex I General Safety and Performance Requirements mapped to standards and supporting evidence.
Risk management (ISO 14971)
Risk management plan, hazard analysis and benefit-risk conclusions linked to performance evidence and the rest of the documentation.
Performance evaluation (Annex XIII)
Performance evaluation plan and report bringing together scientific validity, analytical performance and clinical performance evidence.
Verification and validation
Analytical and clinical performance studies, specimen stability, software validation and other verification evidence relevant to your IVD.
Post-market surveillance and PMPF
Annex III PMS documentation: PMS reports for Class A and B, PSURs for Class C and D, and Annex XIII post-market performance follow-up (PMPF) plans and reports.
How Obodux IVDR will work
Bring in what you already have
Upload existing documentation for organisation against IVDR Annex II, III and XIII.
See the gaps
Identify missing or referenced-but-absent evidence against the IVDR structure. You can also request a free gap analysis to discuss your current documentation.
Draft with AI assistance
Planned guided templates and AI drafting will help address gaps. Every suggestion will remain yours to review, edit and approve.
Get specialist review
Plan specialist review of your IVDR documentation and performance evaluation where a second pair of eyes is needed.
Keep it current
Keep PMS findings, PMPF outputs and performance evaluation updates connected as evidence changes, with planned version history and an audit trail.
Obodux compared with the usual approaches
| Word and SharePoint | Consultant only | Obodux IVDR (coming soon) | |
|---|---|---|---|
| Structure | Folder structure you design and maintain | Depends on the consultant | Planned around IVDR Annex II, III and XIII |
| Finding gaps | Manual cross-checking | Paid review, usually point in time | Planned IVDR evidence gap analysis |
| Drafting | From scratch or old templates | Written for you, at day rates | Planned AI-assisted drafting your team controls |
| Expert input | None built in | Yes | Specialist review planned for IVDR documentation |
| Audit trail | Limited version history | Held by the consultant | Planned change history in one workspace |
Who it is for
- Small and mid-sized IVD manufacturers preparing for the EU market
- RA/QA leads and founders assembling IVDR technical documentation and performance evidence
- Teams transitioning legacy IVDD devices to IVDR
- Manufacturers of Class A to D IVDs classified under Annex VIII, including teams also considering UKCA documentation for Great Britain
Common questions
Does Obodux replace our ISO 13485 QMS?
No. Obodux IVDR is being developed to sit alongside your quality management system and focus on technical documentation. Your QMS procedures and document control remain your responsibility.
Will Obodux IVDR support the IVDD to IVDR transition?
That is the planned focus: organise legacy IVDD documentation, identify gaps against IVDR Annex II and III, and assemble Annex XIII performance evaluation and PMPF evidence. Our guide to MDR and IVDR transition deadlines explains the timelines.
Will using Obodux guarantee CE marking?
No. Obodux is a documentation tool with optional specialist review. It does not provide legal or regulatory advice, and your organisation remains responsible for its technical documentation and submissions.
How do we try it?
Obodux IVDR is coming soon. Join early access to register your interest; IVDR access is not yet available.
IVDR documentation software is coming soon
Join the early access list for Obodux IVDR, or request a free gap analysis to discuss your current documentation.
Join early accessGet a free gap analysisObodux is a documentation tool from BORIS Software Ltd. It does not provide legal or regulatory advice and does not guarantee CE, UKCA or any other approval. AI suggestions are guidance only, and manufacturers remain responsible for their technical documentation. Further reading: IVDR transition deadlines, EU MDR, IVDR and UKCA glossary.

